Literature DB >> 23707175

Lisfranc injury in the athlete: evidence supporting management from sprain to fracture dislocation.

Kyriacos I Eleftheriou1, Peter F Rosenfeld.   

Abstract

Although Lisfranc injuries are uncommon, prompt and accurate diagnosis of such injuries in athletes is essential in preventing career-ending injury. Undisplaced injuries have an excellent result with nonoperative treatment. The presence of any displacement warrants open reduction and anatomic fixation; although current evidence mostly supports screw fixation, plate fixation may avoid joint intrusion. It is imperative to warn athletes with significantly displaced injuries that there is a risk of a poor outcome, although some recent evidence suggests that return to elite competitive sports is still likely after surgical intervention. Severe injuries may have better outcomes with limited arthrodesis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23707175     DOI: 10.1016/j.fcl.2013.02.004

Source DB:  PubMed          Journal:  Foot Ankle Clin        ISSN: 1083-7515            Impact factor:   1.653


  4 in total

1.  [Effectiveness of open reduction and internal fixation for acute and delayed occult Lisfranc injuries].

Authors:  Shizhou Wu; Boquan Qin; Huiqi Xie; Fuguo Huang; Hui Zhang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-08-15

2.  [Development and clinical application of ankle prosthesis].

Authors:  Pengfei Bu; Chuan Li; Jun Li; Min Zhu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-11-15

3.  Return to Sport after Surgical Treatment of Lisfranc Injuries in Athletes: A Retrospective Case Series.

Authors:  Bryan G Vopat; Matthew L Vopat; Pim A D van Dijk; Sean Hazzard; Kayla McKinnon; Peter D Asnis; George H Theodore
Journal:  Kans J Med       Date:  2019-11-25

4.  Functional outcome of tarsometatarsal joint fracture dislocation managed according to Myerson classification.

Authors:  Xiao Yu; Qing-Jiang Pang; Chang-Chun Yang
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.